Ebola and Marburg Virus Vaccines

Clinical trial NCT00605514 · COMPLETED

Trial details

NCT number: NCT00605514
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ebola Vaccines Marburg Virus Disease Ebola Virus Disease Marburgvirus Ebolavirus

Start date: 2008-01-25
Primary completion: 2010-06-21
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.